Matinas BioPharma Holdings (MTNB) Stock Price & Financial Analysis
Matinas BioPharma Holdings Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Matinas BioPharma Holdings
What is the current stock price for MTNB?
As of the latest trading session, MTNB stock trades at $0.56. The 52-week range is $0.48–$3.09, with a day range of $0.48–$0.77.
What is the P/E ratio for MTNB?
The P/E ratio (Price-to-Earnings) for MTNB is shown in the Key Statistics section. This valuation metric helps compare Matinas BioPharma Holdings, Inc. to industry peers.
Does MTNB pay dividends?
Matinas BioPharma Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for MTNB?
Analyst ratings and recommendations for MTNB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of MTNB?
Matinas BioPharma Holdings's market capitalization is $3.0M, classifying it as a micro-cap company. Matinas BioPharma Holdings operates in the Healthcare sector within the Biotechnology industry.